These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28248208)

  • 21. Liver support systems.
    Santoro A; Mancini E; Ferramosca E; Faenza S
    Contrib Nephrol; 2007; 156():396-404. PubMed ID: 17464150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of albumin dialysis devices molecular adsorbent recirculating system and ADVanced Organ Support system in critically ill patients with liver failure-A retrospective analysis.
    Falkensteiner C; Kortgen A; Leonhardt J; Bauer M; Sponholz C
    Ther Apher Dial; 2021 Apr; 25(2):225-236. PubMed ID: 32515160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children.
    Schaefer B; Schmitt CP
    Pediatr Nephrol; 2013 Sep; 28(9):1763-9. PubMed ID: 23179193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Extracorporeal liver support of liver failure].
    Gerth HU; Pohlen M; Pavenstädt H; Schmidt H
    Z Gastroenterol; 2017 Apr; 55(4):383-393. PubMed ID: 28293919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracorporeal liver support: waiting for the deciding vote.
    Adham M
    ASAIO J; 2003; 49(6):621-32. PubMed ID: 14655724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Evidence for Extracorporeal Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure.
    Karvellas CJ; Subramanian RM
    Crit Care Clin; 2016 Jul; 32(3):439-51. PubMed ID: 27339682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure--a prospective, randomised crossover study.
    Sponholz C; Matthes K; Rupp D; Backaus W; Klammt S; Karailieva D; Bauschke A; Settmacher U; Kohl M; Clemens MG; Mitzner S; Bauer M; Kortgen A
    Crit Care; 2016 Jan; 20():2. PubMed ID: 26728364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects for extracorporeal liver support.
    Jalan R; Sen S; Williams R
    Gut; 2004 Jun; 53(6):890-8. PubMed ID: 15138219
    [No Abstract]   [Full Text] [Related]  

  • 29. Albumin dialysis MARS: knowledge from 10 years of clinical investigation.
    Mitzner SR; Stange J; Klammt S; Koball S; Hickstein H; Reisinger EC
    ASAIO J; 2009; 55(5):498-502. PubMed ID: 19730006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: a meta-analysis.
    Khuroo MS; Khuroo MS; Farahat KL
    Liver Transpl; 2004 Sep; 10(9):1099-106. PubMed ID: 15349999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).
    Mitzner SR
    Ann Hepatol; 2011 May; 10 Suppl 1():S21-8. PubMed ID: 21566251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bridging therapies and liver transplantation in acute liver failure, 10 years of MARS experience from Finland.
    Kantola T; Ilmakunnas M; Koivusalo AM; Isoniemi H
    Scand J Surg; 2011; 100(1):8-13. PubMed ID: 21482500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications and therapeutic possibilities of albumin dialysis (MARS).
    Bañares Cañizares R; Catalina Rodríguez MV
    Rev Esp Enferm Dig; 2003 Dec; 95(12):876-89. PubMed ID: 14972008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The elusive goal of liver support--quest for the Holy Grail.
    Williams R
    Clin Med (Lond); 2006; 6(5):482-7. PubMed ID: 17080897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase of octanoate concentrations during extracorporeal albumin dialysis treatments.
    Klammt S; Koball S; Hickstein H; Gloger M; Henschel J; Mitzner S; Stange J; Reisinger EC
    Ther Apher Dial; 2009 Oct; 13(5):437-43. PubMed ID: 19788462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure.
    Oettl K; Stadlbauer V; Krisper P; Stauber RE
    Ther Apher Dial; 2009 Oct; 13(5):431-6. PubMed ID: 19788461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MARS: Should I Use It?
    Cheungpasitporn W; Thongprayoon C; Zoghby ZM; Kashani K
    Adv Chronic Kidney Dis; 2021 Jan; 28(1):47-58. PubMed ID: 34389137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
    Marangoni R
    G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study.
    Choi JY; Bae SH; Yoon SK; Cho SH; Yang JM; Han JY; Ahn BM; Chung KW; Sun HS; Kim DG
    Liver Int; 2005 Aug; 25(4):740-5. PubMed ID: 15998424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The clinical experience with MARS and Prometheus procedures].
    Hydzik P; Gawlikowski T; Ciszowski K; Sułlek M
    Przegl Lek; 2007; 64(4-5):352-4. PubMed ID: 17724911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.